HC Wainwright Issues Negative Forecast for ZNTL Earnings
Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2025 EPS estimates for shares of Zentalis Pharmaceuticals in a research note issued on Thursday, March 27th. HC Wainwright analyst A. Fein now expects that the company will post earnings of ($0.52) per share for the quarter, down from […]
